Sunday, May 20, 2018
One of America's Great Newspapers ~ Toledo, Ohio


Local drug firm gains $300,000 investment

A Regional Growth Partnership venture capital fund announced yesterday it will invest $300,000 in a local pharmaceutical company that is to begin clinical trials in Toledo for a drug to treat Alzheimer s and other nervous-system diseases.

The Rocket Ventures investment is with Madison, Wis.-based Mithridion Inc., successor to Cognitive Pharmaceuticals Ltd., a firm set up by University of Toledo Profs. Wayne Hoss and William Messer, Jr.

Mithridion took over Cognitive Pharmaceuticals last month with $2.3 million in financing from a Wisconsin venture capital firm. Dr. Hoss said its drug for Alzheimer s differs from others by treating memory loss, confusion, and other symptoms and also getting at underlying causes of the disease and protecting the brain.

Click to comment

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem?

Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet.

Copyright © 2018 Toledo Blade

To Top

Fetching stories…